(Q51234986)

English

Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trial.

scientific article published in April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/16584432

Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/16584432

author name string

Alvaro Pineda

1

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/16584432

Jeffrey McCullough

2

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/16584432

Richard J Benjamin

3

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/16584432

Ritchard Cable

4

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/16584432

Ronald G Strauss

5

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/16584432

Edwin Burgstaler

6

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/16584432

Seth Porter

7

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/16584432

Lily Lin

8

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/16584432

Peyton Metzel

9

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/16584432

Maureen G Conlan

10

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/16584432

SPRINT Study Group

11

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/16584432

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/16584432

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/16584432

46

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/16584432

4

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/16584432

562-571

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/16584432

Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening. The Transfusion Safety Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00761.X

21 January 2018

Current and emerging infectious risks of blood transfusions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00761.X

21 January 2018

The French haemovigilance system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00761.X

21 January 2018

Improving the bacteriological safety of platelet transfusions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00761.X

21 January 2018

NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00761.X

21 January 2018

First report of human immunodeficiency virus transmission via an RNA-screened blood donation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00761.X

21 January 2018

Transmission of tick-borne agents of disease by blood transfusion: a review of known and potential risks in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00761.X

21 January 2018

Transfusion-transmitted malaria in the United States from 1963 through 1999.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00761.X

21 January 2018

Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00761.X

21 January 2018

Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00761.X

21 January 2018

Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00761.X

21 January 2018

Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen (amotosalen HCl) and long-wavelength UV.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00761.X

21 January 2018

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00761.X

21 January 2018

Pharmacokinetic and toxicology assessment of INTERCEPT (S-59 and UVA treated) platelets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00761.X

21 January 2018

The role of toxicology assessment in transfusion medicine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00761.X

21 January 2018

Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00761.X

21 January 2018

Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00761.X

21 January 2018

Identifiers

10.1111/J.1537-2995.2006.00761.X

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/16584432

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/16584432

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51234986&oldid=938347422"